2026-09-25 · 2026-09 / week-4
Summary: RAVE’s FY2026 audited filing shows $13.61 million of cash and Treasury bills against $2.206 million of total liabilities, while adjusted EBITDA rose to $3.948 million. But fourth-quarter comparable retail sales ...
2026-09-25 · 2026-09 / week-4
Summary: Darden’s fiscal Q1 FY2027 release confirms positive comparable sales across every reported segment, but the consolidated 3.1% comp masks a split between Olive Garden at 1.1% and LongHorn at 6.2%. The FY27 EPS ou...
2026-09-24 · 2026-09 / week-4
Summary: Cracker Barrel’s FY2027 adjusted EBITDA guide of $180–$200 million implies roughly 29% growth at the midpoint from a weak FY2026 base. Yet the latest quarter’s restaurant comps fell 2.1%, restaurant traffic fell...
2026-09-23 · 2026-09 / week-4
Summary: General Mills’ first-quarter FY2027 organic sales were flat and adjusted EPS of $0.75 topped a $0.72 calendar estimate. But organic volume fell 1%, North America Retail organic sales fell 3%, adjusted operating ...
2026-09-23 · 2026-09 / week-4
Summary: At the September 22 close of $35.45, General Mills trades at about 11.4 times the midpoint of its FY2027 adjusted-EPS guide, but that guide already embeds an 8%–13% constant-currency operating-profit decline. Ma...
2026-09-23 · 2026-09 / week-4
Summary: THOR's fiscal Q4 diluted EPS fell 66.9% and adjusted EBITDA fell 37.1%, yet the stock closed up 5.52% after the release. FY2026 sales beat the top of the company's prior range, North American Towable backlog ros...
2026-09-23 · 2026-09 / week-4
Summary: Cintas enters its Q1 FY2027 release after record FY2026 gross margin, 8.3% organic revenue growth, and an adjusted-EPS guide of $5.36–$5.50. But at the September 22 close of $198.80, the midpoint guide implies 3...
2026-09-23 · 2026-09 / week-4
Summary: Worthington Enterprises’ Q1 FY2027 release reported 7% organic sales growth and $54 million of free cash flow, but adjusted operating income was flat, part of the increase came from acquisitions and a $4 million...
2026-09-23 · 2026-09 / week-4
Summary: MillerKnoll's fiscal Q1 adjusted EPS rose 18%, but $0.11 per share came from a one-time tariff refund; excluding it, adjusted EPS was about $0.42, below the prior-year $0.45. The sales guide was trimmed while EP...
2026-09-23 · 2026-09 / week-4
Summary: KB Home’s Q3 FY2026 backlog grew for the first time in four years, but orders still fell 12%, cancellations rose, homebuilding margin compressed, and nine-month net income fell 61%. At the September 22 regular c...
2026-09-22 · 2026-09 / week-4
Summary: Gauzy disclosed a Nasdaq delisting notice for failing the minimum-bid rule and for delinquent 2025 Form 20-F reporting. The company intends to appeal by September 22, which would stay delisting while the panel r...
2026-09-22 · 2026-09 / week-4
Summary: AutoZone reports fiscal Q4 2026 before the market opens on September 22, with consensus near $54.30 EPS and approximately $6.71 billion revenue. Its latest filed quarter showed 8.4% sales growth, 3.9% constant-c...
2026-09-22 · 2026-09 / week-4
Summary: Newcleo completed its business combination with NewHold and will begin trading on Nasdaq under NWCL on September 22. The transaction provides approximately $247 million of gross proceeds and values newcleo at ro...
2026-09-21 · 2026-09 / week-4
Summary: VisionWave filed a 1-for-20 reverse stock split effective September 22, intended to lift the trading price and maintain Nasdaq compliance. The same capital structure includes an ATM and potential dilution while ...
2026-09-21 · 2026-09 / week-4
Summary: Knightscope filed a prospectus supplement increasing its at-the-market program by $32.5 million to a total $35 million. The company is a thinly traded security-robotics issuer and the filing arrives while financ...
2026-09-21 · 2026-09 / week-4
Summary: Lakewood-Amedex highlighted preclinical Nu-3 safety, an upcoming Phase 2a diabetic-foot-ulcer trial and a new Australian patent. It also asked shareholders to increase authorized common shares from 12.5 million ...
2026-09-21 · 2026-09 / week-4
Summary: Incyte’s partner expanded an existing agreement to commercialize ruxolitinib cream in Australia. The product is already approved and commercialized in other jurisdictions, while the Australian launch remains sub...
2026-09-21 · 2026-09 / week-4
Summary: Change Agents said Nasdaq confirmed compliance with the $1.00 minimum-bid rule after ten qualifying sessions from August 31 through September 14. CHGA closed at $2.07 on September 18, 2026, after a 1.72% session...
2026-09-21 · 2026-09 / week-4
Summary: Eightco Holdings reported approximately $380 million of holdings as of September 16, including indirect OpenAI and Beast Industries investments, 16,278 ETH, nearly 302 million WLD tokens and about $120 million o...
2026-09-20 · 2026-09 / week-3
Summary: Hyperscale Data says it held approximately $51 million of Bitcoin, cash and restricted cash on September 13, or 136% of its common-stock market capitalization using the September 14 close. Management also says t...